BionicM Secures JPY 710 Million in Series B Funding to Fuel U.S. Expansion
Tokyo-based BionicM Inc. has successfully closed the first stage of its Series B financing round, raising JPY 710 million (approximately USD 4.5 million). This brings the company's total funding, including equity and government grants, to JPY 2.58 billion. The capital injection is intended to bolster manufacturing infrastructure and expand sales and marketing efforts in the United States. The funds will specifically support the upcoming 2027 commercial launch of ASISTA™, a next-generation powered prosthetic knee that utilizes robotic actuation technology rather than traditional passive hydraulic systems. This move aligns with shifting U.S. regulatory landscapes and new reimbursement codes for electromechanical controlled prosthetics, positioning BionicM to capitalize on the growing demand for active movement-assisting medical devices.
Topics: Medical Devices Robotics Series B financing Venture Capital